Search by Drug Name or NDC
NDC 00074-1040-04 Survanta 25 mg/mL Details
Survanta 25 mg/mL
Survanta is a ENDOTRACHEAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is BERACTANT.
Product Information
| NDC | 00074-1040 |
|---|---|
| Product ID | 0074-1040_d7b22199-8b83-4205-b830-a6942b2249db |
| Associated GPIs | 45000050111820 |
| GCN Sequence Number | 016280 |
| GCN Sequence Number Description | beractant VIAL 25 MG/ML INHALATION |
| HIC3 | B1A |
| HIC3 Description | LUNG SURFACTANTS |
| GCN | 02871 |
| HICL Sequence Number | 006193 |
| HICL Sequence Number Description | BERACTANT |
| Brand/Generic | Brand |
| Proprietary Name | Survanta |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Beractant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ENDOTRACHEAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/mL |
| Substance Name | BERACTANT |
| Labeler Name | AbbVie Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA020032 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00074-1040-04 (00074104004)
| NDC Package Code | 0074-1040-04 |
|---|---|
| Billing NDC | 00074104004 |
| Package | 1 VIAL, SINGLE-USE in 1 CARTON (0074-1040-04) / 4 mL in 1 VIAL, SINGLE-USE |
| Marketing Start Date | 1991-07-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |